Wellfully Overview
- Founded
-
1992
- Status
-
Public
- Employees
-
1
- Stock Symbol
-
WFL
- Investments
-
1
- Share Price
-
$0.03
- (As of Thursday Closing)
Wellfully General Information
Description
Wellfully Ltd is engaged in the research and development for Dermaportation and ETP transdermal drug delivery technologies. The company operates in segments namely development of the dermaportation drug delivery technology and Devices segments. Geographically, it derives a majority of revenue from Singapore and also has a presence in Japan. It serves Pharmaceutical; Cosmetics and Skincare and Consumer Healthcare industries.
Contact Information
Website
www.wellfully.net
Formerly Known As
OBJ Ltd., OBJ
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Delivery
Stock Exchange
ASX
Primary Office
- 284 Oxford Street
- Leederville, Western Australia 6007
- Australia
Wellfully Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.03 | $0.03 | $0.02 - $0.14 | $7.65M | 275M | 736K |
Wellfully Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2022 30-Jun-2022 | FY 2021 30-Jun-2021 | FY 2020 30-Jun-2020 |
|---|---|---|---|---|
| EV | 7,744 | 7,744 | 6,032 | |
| Revenue | 297 | 45 | ||
| EBITDA | (4,688) | (2,498) | ||
| Net Income | (4,769) | (2,487) | ||
| Total Assets | 2,549 | 819 | ||
| Total Debt | 198 | 718 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Wellfully Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Wellfully Patents
Wellfully Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2011519638-A | Method and apparatus for promoting transdermal diffusion | Pending | 07-May-2008 | 000000000 | 0 |
| EP-2303393-A4 | Method and apparatus for enhanced transdermal diffusion | Withdrawn | 07-May-2008 | 000000000 | 0 |
| EP-2303393-A1 | Method and apparatus for enhanced transdermal diffusion | Withdrawn | 07-May-2008 | 000000000 | 0 |
| US-20110201869-A1 | Method and apparatus for enhanced transdermal diffusion | Abandoned | 07-May-2008 | 000000000 | 00 |
| AU-2008355879-A1 | Method and apparatus for enhanced transdermal diffusion | Abandoned | 07-May-2008 | A61M37/00 |
Wellfully Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Paul Peros | Chief Executive Officer | ||
| Jeffrey Edwards | Founder & Director |
Wellfully Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Wellfully Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 000 | 18-Feb-2020 | 0000000000 | 0000 | Food Products |
Wellfully Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000000000 0000000 | Food Products | Arndell Park, Australia |